Efficacy of switching to 0.1% Brimonidine Tartrate in glaucoma patients under combined theraphy.

Efficacy of switching to 0.1% Brimonidine Tartrate in glaucoma patients under combined theraphy. - Efficacy of switching to 0.1% Brimonidine Tartrate.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010978

Enrollment

Registered

2013-06-24

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Period, between April 2013 from June 2012. Target, 32 eye 19 cases of glaucoma patients Yamagata University Medical Hospital ophthalmology hospital. The method, and tha results were compared before a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Glaucoma patient to be treated multidrug combination was also determined effect is insufficient clinically.

Exclusion criteria

Exclusion criteria: Glaucoma patient that it is determined effect is sufficient clinically in the treatment of current.

Design outcomes

Primary

Measure	Time frame
Target 32 eye 19 cases glaucome patients during the period April 2013 from June 2012, to perform the treatment combination multidrug in Yamagata University Medical Hospital ophthalmology hospital was also determined effect is insufficient clinically. Were compared before and after the switch to 0.1% brimonidine tartrate ophthalmic solution 1 agents already in use without providing the washout period, the switching effect lowering IOP.	—

Measure

Time frame

Target 32 eye 19 cases glaucome patients during the period April 2013 from June 2012, to perform the treatment combination multidrug in Yamagata University Medical Hospital ophthalmology hospital was also determined effect is insufficient clinically. Were compared before and after the switch to 0.1% brimonidine tartrate ophthalmic solution 1 agents already in use without providing the washout period, the switching effect lowering IOP.

—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026